0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global POC Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-12137
Home | Market Reports | Health| Medical Facilities & Services
Global POC Diagnostics Market Insights and Forecast to 2028
BUY CHAPTERS

Global POC Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-12137
Report
May 2025
Pages:175
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

POC Diagnostics Market Size

In 2024, the global market size of POC Diagnostics was estimated to be worth US$ 30680 million and is forecast to reach approximately US$ 57050 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.

POC Diagnostics Market

POC Diagnostics Market

Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
In United States, POC Diagnostics key players include Alere, Roche, Abbott Laboratories, Johnson & Johnson, etc. Global top four manufacturers hold a share over 50%.
In terms of product, Blood Glucose Testing is the largest segment, with a share over 45%. And in terms of application, the largest application is Clinics, followed by Hospitals, Laboratory, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for POC Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POC Diagnostics.
The POC Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global POC Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the POC Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of POC Diagnostics Market Report

Report Metric Details
Report Name POC Diagnostics Market
CAGR 9.4%
Segment by Type
Segment by Application
  • Clinics
  • Hospitals
  • Laboratory
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, Bayer Healthcare, Beckman Coulter, Nipro Diagnostics, Bio-Rad Laboratories, Nova Biomedical, BioMerieux, Quidel, Helena Laboratories, OraSure Technologies, Accriva, Abaxis, Chembio Diagnostics, Trinity Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of POC Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of POC Diagnostics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, POC Diagnostics sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in POC Diagnostics Market?

Ans: Global top four manufacturers hold a share over 50%.

What is the POC Diagnostics Market share by type?

Ans: In terms of product, Blood Glucose Testing is the largest segment, with a share over 45%.

Who are the main players in the POC Diagnostics Market report?

Ans: The main players in the POC Diagnostics Market are Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, Bayer Healthcare, Beckman Coulter, Nipro Diagnostics, Bio-Rad Laboratories, Nova Biomedical, BioMerieux, Quidel, Helena Laboratories, OraSure Technologies, Accriva, Abaxis, Chembio Diagnostics, Trinity Biotech

What are the Application segmentation covered in the POC Diagnostics Market report?

Ans: The Applications covered in the POC Diagnostics Market report are Clinics, Hospitals, Laboratory, Others

What are the Type segmentation covered in the POC Diagnostics Market report?

Ans: The Types covered in the POC Diagnostics Market report are Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas or Electrolytes Testing, Tumor Markers Testing, Urinalysis Testing, Cholesterol Testing, Others

Recommended Reports

POC Diagnostics

POC Analyzers

POC Disease Testing

Market trends :

Topic Trends
Global the global poc diagnostics market is experiencing robust growth driven by rapid adoption in clinics, technological advancements, and increasing demand for immediate patient care solutions.
Type Blood Glucose Testing - blood glucose testing remains the largest segment, driven by rising diabetes prevalence and demand for immediate results.
Infectious Diseases Testing - infectious diseases testing is experiencing strong growth due to increased focus on rapid detection and outbreak management.
Cardiac Markers Testing - cardiac markers testing is gaining traction as healthcare providers prioritize early diagnosis of cardiovascular events.
Coagulation Testing - coagulation testing is expanding in hospitals and clinics for faster patient management in emergency and surgical settings.
Pregnancy and Fertility Testing - pregnancy and fertility testing continues to see steady demand in both clinical and at-home settings.
Blood Gas or Electrolytes Testing - blood gas or electrolytes testing is advancing with new portable analyzers for critical care environments.
Tumor Markers Testing - tumor markers testing is growing as oncology care increasingly adopts rapid diagnostic solutions.
Urinalysis Testing - urinalysis testing is being enhanced with automated poc devices for faster and more accurate results.
Cholesterol Testing - cholesterol testing at the point of care is expanding to support preventive health initiatives.
Application Clinics - clinics represent the largest application segment, leveraging poc diagnostics for rapid patient triage and management.
Hospitals - hospitals are increasing adoption of poc diagnostics to streamline workflows and improve patient outcomes.
Laboratory - laboratories are integrating advanced poc devices to complement traditional testing and reduce turnaround times.
Company Alere - alere continues to lead in blood glucose testing solutions, maintaining significant presence in the us poc diagnostics market.
Roche - roche is expanding its poc diagnostics portfolio with innovative products targeting infectious disease and cardiac marker testing.
Abbott Laboratories - abbott laboratories is strengthening its market position through new product launches and expanded distribution in emerging markets.
Johnson & Johnson - johnson & johnson focuses on integrating advanced technologies into its poc diagnostics offerings to enhance clinical decision-making.
Siemens Healthcare - siemens healthcare is investing in next-generation poc devices for coagulation and blood gas testing to meet rising clinical demand.
Danaher - danaher is leveraging acquisitions and r&d to broaden its poc diagnostics product range, especially in cardiac and infectious disease testing.
Bayer Healthcare - bayer healthcare is optimizing its poc diagnostics solutions for improved accuracy and faster turnaround times in clinical settings.
Beckman Coulter - beckman coulter is enhancing its poc diagnostics capabilities with new urinalysis and coagulation testing platforms.
Nipro Diagnostics - nipro diagnostics is expanding its blood glucose testing solutions to address growing demand in both developed and emerging markets.
Bio-Rad Laboratories - bio-rad laboratories is focusing on innovation in tumor marker and infectious disease poc testing to capture new market segments.
Nova Biomedical - nova biomedical is advancing its blood gas and electrolyte poc analyzers for improved patient outcomes in critical care.
BioMerieux - biomerieux is driving growth through the development of rapid infectious disease poc diagnostics for global deployment.
Quidel - quidel is expanding its portfolio of rapid diagnostic tests for clinics, emphasizing infectious disease and pregnancy testing.
Helena Laboratories - helena laboratories is strengthening its presence in coagulation and urinalysis poc testing for hospital and laboratory applications.
OraSure Technologies - orasure technologies is focusing on innovative rapid diagnostic solutions for infectious diseases and at-home testing.
Accriva - accriva is enhancing its coagulation poc testing platforms to support faster clinical decision-making in acute care.
Abaxis - abaxis is expanding its range of compact poc analyzers for clinics and hospitals, targeting blood chemistry and hematology testing.
Chembio Diagnostics - chembio diagnostics is launching new rapid tests for infectious diseases to address global health challenges.
Trinity Biotech - trinity biotech is innovating in the field of urinalysis and infectious disease poc diagnostics to increase market penetration.
Region North America - north america leads in poc diagnostics adoption due to advanced healthcare infrastructure and high chronic disease burden.
EMEA - emea is witnessing steady growth in poc diagnostics driven by regulatory support and expanding healthcare access.
APAC - apac is experiencing rapid market expansion fueled by rising healthcare investments and increasing awareness of poc testing.
LATAM - latam is seeing growing demand for affordable poc diagnostics as healthcare systems focus on improving accessibility.
1 Study Coverage
1.1 POC Diagnostics Product Introduction
1.2 Market by Type
1.2.1 Global POC Diagnostics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas or Electrolytes Testing
1.2.8 Tumor Markers Testing
1.2.9 Urinalysis Testing
1.2.10 Cholesterol Testing
1.3 Market by Application
1.3.1 Global POC Diagnostics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global POC Diagnostics Market Size Estimates and Forecasts
2.1.1 Global POC Diagnostics Revenue 2020-2031
2.1.2 Global POC Diagnostics Sales 2020-2031
2.2 POC Diagnostics Market Size by Region: 2024 Versus 2031
2.3 POC Diagnostics Sales by Region (2020-2031)
2.3.1 Global POC Diagnostics Sales by Region: 2020-2025
2.3.2 Global POC Diagnostics Sales Forecast by Region (2026-2031)
2.3.3 Global POC Diagnostics Sales Market Share by Region (2020-2031)
2.4 POC Diagnostics Market Estimates and Projections by Region (2026-2031)
2.4.1 Global POC Diagnostics Revenue by Region: 2020-2025
2.4.2 Global POC Diagnostics Revenue Forecast by Region (2026-2031)
2.4.3 Global POC Diagnostics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global POC Diagnostics Sales by Type (2020-2031)
3.1.1.1 Global POC Diagnostics Sales Volume by Type (2020-2031)
3.1.1.2 Global POC Diagnostics Sales Market Share by Type (2020-2031)
3.1.2 Global POC Diagnostics Revenue by Type (2020-2031)
3.1.2.1 Global POC Diagnostics Revenue by Type (2020-2031)
3.1.2.2 Global POC Diagnostics Revenue Market Share by Type (2020-2031)
3.1.3 POC Diagnostics Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global POC Diagnostics Sales by Application (2020-2031)
3.2.1.1 Global POC Diagnostics Sales Volume by Application (2020-2031)
3.2.1.2 Global POC Diagnostics Sales Market Share by Application (2020-2031)
3.2.2 Global POC Diagnostics Revenue by Application (2020-2031)
3.2.2.1 Global POC Diagnostics Revenue by Application (2020-2031)
3.2.2.2 Global POC Diagnostics Revenue Market Share by Application (2020-2031)
3.2.3 POC Diagnostics Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Blood Glucose Testing of POC Diagnostics Revenue Market Share by Application
3.3.2 Infectious Diseases Testing of POC Diagnostics Revenue Market Share by Application
3.3.3 Cardiac Markers Testing of POC Diagnostics Revenue Market Share by Application
3.3.4 Coagulation Testing of POC Diagnostics Revenue Market Share by Application
3.3.5 Pregnancy and Fertility Testing of POC Diagnostics Revenue Market Share by Application
3.3.6 Blood Gas or Electrolytes Testing of POC Diagnostics Revenue Market Share by Application
3.3.7 Tumor Markers Testing of POC Diagnostics Revenue Market Share by Application
3.3.8 Urinalysis Testing of POC Diagnostics Revenue Market Share by Application
3.3.9 Cholesterol Testing of POC Diagnostics Revenue Market Share by Application
4 Global POC Diagnostics by Manufacturers
4.1 Global Top POC Diagnostics Manufacturers by Sales (2020-2025)
4.1.1 Global POC Diagnostics Sales by Manufacturer (2020-2025)
4.1.2 Global POC Diagnostics Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top POC Diagnostics Manufacturers by Revenue (2020-2025)
4.2.1 Global POC Diagnostics Revenue by Manufacturer (2020-2025)
4.2.2 Global POC Diagnostics Revenue Share by Manufacturer (2020-2025)
4.3 Global POC Diagnostics Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key POC Diagnostics Manufacturers Covered: Ranking by Revenue
4.4.2 Global POC Diagnostics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global POC Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global POC Diagnostics Manufacturing Base Distribution, Product Type
4.5.1 POC Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into POC Diagnostics Market
4.5.3 Manufacturers POC Diagnostics Product Type and Application
4.5.4 Blood Glucose Testing Market Sales of POC Diagnostics by Manufacturer
4.5.5 Infectious Diseases Testing Market Sales of POC Diagnostics by Manufacturer
4.5.6 Cardiac Markers Testing Market Sales of POC Diagnostics by Manufacturer
4.5.7 Coagulation Testing Market Sales of POC Diagnostics by Manufacturer
4.5.8 Pregnancy and Fertility Testing Market Sales of POC Diagnostics by Manufacturer
4.5.9 Blood Gas or Electrolytes Testing Market Sales of POC Diagnostics by Manufacturer
4.5.10 Tumor Markers Testing Market Sales of POC Diagnostics by Manufacturer
4.5.11 Urinalysis Testing Market Sales of POC Diagnostics by Manufacturer
4.5.12 Cholesterol Testing Market Sales of POC Diagnostics by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Alere
5.1.1 Alere Company Information
5.1.2 Alere Description, Business Overview
5.1.3 Alere POC Diagnostics Products Offered
5.1.4 Alere POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Alere POC Diagnostics Sales by Product in 2024
5.1.6 Alere POC Diagnostics Sales by Application in 2024
5.1.7 Alere POC Diagnostics Sales by Geographic Area in 2024
5.1.8 Alere Recent Developments
5.2 Roche
5.2.1 Roche Company Information
5.2.2 Roche Description, Business Overview
5.2.3 Roche POC Diagnostics Products Offered
5.2.4 Roche POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Roche POC Diagnostics Sales by Product in 2024
5.2.6 Roche POC Diagnostics Sales by Application in 2024
5.2.7 Roche POC Diagnostics Sales by Geographic Area in 2024
5.2.8 Roche Recent Developments
5.3 Abbott Laboratories
5.3.1 Abbott Laboratories Company Information
5.3.2 Abbott Laboratories Description, Business Overview
5.3.3 Abbott Laboratories POC Diagnostics Products Offered
5.3.4 Abbott Laboratories POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Abbott Laboratories POC Diagnostics Sales by Product in 2024
5.3.6 Abbott Laboratories POC Diagnostics Sales by Application in 2024
5.3.7 Abbott Laboratories POC Diagnostics Sales by Geographic Area in 2024
5.3.8 Abbott Laboratories Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Company Information
5.4.2 Johnson & Johnson Description, Business Overview
5.4.3 Johnson & Johnson POC Diagnostics Products Offered
5.4.4 Johnson & Johnson POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Johnson & Johnson POC Diagnostics Sales by Product in 2024
5.4.6 Johnson & Johnson POC Diagnostics Sales by Application in 2024
5.4.7 Johnson & Johnson POC Diagnostics Sales by Geographic Area in 2024
5.4.8 Johnson & Johnson Recent Developments
5.5 Siemens Healthcare
5.5.1 Siemens Healthcare Company Information
5.5.2 Siemens Healthcare Description, Business Overview
5.5.3 Siemens Healthcare POC Diagnostics Products Offered
5.5.4 Siemens Healthcare POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Siemens Healthcare POC Diagnostics Sales by Product in 2024
5.5.6 Siemens Healthcare POC Diagnostics Sales by Application in 2024
5.5.7 Siemens Healthcare POC Diagnostics Sales by Geographic Area in 2024
5.5.8 Siemens Healthcare Recent Developments
5.6 Danaher
5.6.1 Danaher Company Information
5.6.2 Danaher Description, Business Overview
5.6.3 Danaher POC Diagnostics Products Offered
5.6.4 Danaher POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Danaher POC Diagnostics Sales by Product in 2024
5.6.6 Danaher POC Diagnostics Sales by Application in 2024
5.6.7 Danaher POC Diagnostics Sales by Geographic Area in 2024
5.6.8 Danaher Recent Developments
5.7 Bayer Healthcare
5.7.1 Bayer Healthcare Company Information
5.7.2 Bayer Healthcare Description, Business Overview
5.7.3 Bayer Healthcare POC Diagnostics Products Offered
5.7.4 Bayer Healthcare POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Bayer Healthcare POC Diagnostics Sales by Product in 2024
5.7.6 Bayer Healthcare POC Diagnostics Sales by Application in 2024
5.7.7 Bayer Healthcare POC Diagnostics Sales by Geographic Area in 2024
5.7.8 Bayer Healthcare Recent Developments
5.8 Beckman Coulter
5.8.1 Beckman Coulter Company Information
5.8.2 Beckman Coulter Description, Business Overview
5.8.3 Beckman Coulter POC Diagnostics Products Offered
5.8.4 Beckman Coulter POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Beckman Coulter POC Diagnostics Sales by Product in 2024
5.8.6 Beckman Coulter POC Diagnostics Sales by Application in 2024
5.8.7 Beckman Coulter POC Diagnostics Sales by Geographic Area in 2024
5.8.8 Beckman Coulter Recent Developments
5.9 Nipro Diagnostics
5.9.1 Nipro Diagnostics Company Information
5.9.2 Nipro Diagnostics Description, Business Overview
5.9.3 Nipro Diagnostics POC Diagnostics Products Offered
5.9.4 Nipro Diagnostics POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Nipro Diagnostics POC Diagnostics Sales by Product in 2024
5.9.6 Nipro Diagnostics POC Diagnostics Sales by Application in 2024
5.9.7 Nipro Diagnostics POC Diagnostics Sales by Geographic Area in 2024
5.9.8 Nipro Diagnostics Recent Developments
5.10 Bio-Rad Laboratories
5.10.1 Bio-Rad Laboratories Company Information
5.10.2 Bio-Rad Laboratories Description, Business Overview
5.10.3 Bio-Rad Laboratories POC Diagnostics Products Offered
5.10.4 Bio-Rad Laboratories POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Bio-Rad Laboratories POC Diagnostics Sales by Product in 2024
5.10.6 Bio-Rad Laboratories POC Diagnostics Sales by Application in 2024
5.10.7 Bio-Rad Laboratories POC Diagnostics Sales by Geographic Area in 2024
5.10.8 Bio-Rad Laboratories Recent Developments
5.11 Nova Biomedical
5.11.1 Nova Biomedical Company Information
5.11.2 Nova Biomedical Description, Business Overview
5.11.3 Nova Biomedical POC Diagnostics Products Offered
5.11.4 Nova Biomedical POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Nova Biomedical POC Diagnostics Sales by Product in 2024
5.11.6 Nova Biomedical POC Diagnostics Sales by Application in 2024
5.11.7 Nova Biomedical POC Diagnostics Sales by Geographic Area in 2024
5.11.8 Nova Biomedical Recent Developments
5.12 BioMerieux
5.12.1 BioMerieux Company Information
5.12.2 BioMerieux Description, Business Overview
5.12.3 BioMerieux POC Diagnostics Products Offered
5.12.4 BioMerieux POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.12.5 BioMerieux POC Diagnostics Sales by Product in 2024
5.12.6 BioMerieux POC Diagnostics Sales by Application in 2024
5.12.7 BioMerieux POC Diagnostics Sales by Geographic Area in 2024
5.12.8 BioMerieux Recent Developments
5.13 Quidel
5.13.1 Quidel Company Information
5.13.2 Quidel Description, Business Overview
5.13.3 Quidel POC Diagnostics Products Offered
5.13.4 Quidel POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Quidel POC Diagnostics Sales by Product in 2024
5.13.6 Quidel POC Diagnostics Sales by Application in 2024
5.13.7 Quidel POC Diagnostics Sales by Geographic Area in 2024
5.13.8 Quidel Recent Developments
5.14 Helena Laboratories
5.14.1 Helena Laboratories Company Information
5.14.2 Helena Laboratories Description, Business Overview
5.14.3 Helena Laboratories POC Diagnostics Products Offered
5.14.4 Helena Laboratories POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Helena Laboratories POC Diagnostics Sales by Product in 2024
5.14.6 Helena Laboratories POC Diagnostics Sales by Application in 2024
5.14.7 Helena Laboratories POC Diagnostics Sales by Geographic Area in 2024
5.14.8 Helena Laboratories Recent Developments
5.15 OraSure Technologies
5.15.1 OraSure Technologies Company Information
5.15.2 OraSure Technologies Description, Business Overview
5.15.3 OraSure Technologies POC Diagnostics Products Offered
5.15.4 OraSure Technologies POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.15.5 OraSure Technologies POC Diagnostics Sales by Product in 2024
5.15.6 OraSure Technologies POC Diagnostics Sales by Application in 2024
5.15.7 OraSure Technologies POC Diagnostics Sales by Geographic Area in 2024
5.15.8 OraSure Technologies Recent Developments
5.16 Accriva
5.16.1 Accriva Company Information
5.16.2 Accriva Description, Business Overview
5.16.3 Accriva POC Diagnostics Products Offered
5.16.4 Accriva POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Accriva POC Diagnostics Sales by Product in 2024
5.16.6 Accriva POC Diagnostics Sales by Application in 2024
5.16.7 Accriva POC Diagnostics Sales by Geographic Area in 2024
5.16.8 Accriva Recent Developments
5.17 Abaxis
5.17.1 Abaxis Company Information
5.17.2 Abaxis Description, Business Overview
5.17.3 Abaxis POC Diagnostics Products Offered
5.17.4 Abaxis POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.17.5 Abaxis POC Diagnostics Sales by Product in 2024
5.17.6 Abaxis POC Diagnostics Sales by Application in 2024
5.17.7 Abaxis POC Diagnostics Sales by Geographic Area in 2024
5.17.8 Abaxis Recent Developments
5.18 Chembio Diagnostics
5.18.1 Chembio Diagnostics Company Information
5.18.2 Chembio Diagnostics Description, Business Overview
5.18.3 Chembio Diagnostics POC Diagnostics Products Offered
5.18.4 Chembio Diagnostics POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Chembio Diagnostics POC Diagnostics Sales by Product in 2024
5.18.6 Chembio Diagnostics POC Diagnostics Sales by Application in 2024
5.18.7 Chembio Diagnostics POC Diagnostics Sales by Geographic Area in 2024
5.18.8 Chembio Diagnostics Recent Developments
5.19 Trinity Biotech
5.19.1 Trinity Biotech Company Information
5.19.2 Trinity Biotech Description, Business Overview
5.19.3 Trinity Biotech POC Diagnostics Products Offered
5.19.4 Trinity Biotech POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
5.19.5 Trinity Biotech POC Diagnostics Sales by Product in 2024
5.19.6 Trinity Biotech POC Diagnostics Sales by Application in 2024
5.19.7 Trinity Biotech POC Diagnostics Sales by Geographic Area in 2024
5.19.8 Trinity Biotech Recent Developments
6 North America
6.1 North America POC Diagnostics Market Size YoY Growth 2020-2031
6.2 North America POC Diagnostics Market Facts & Figures by Country
6.2.1 North America POC Diagnostics Sales by Country (2020-2031)
6.2.2 North America POC Diagnostics Revenue by Country (2020-2031)
6.3 North America POC Diagnostics Sales by Type (2020-2025)
6.4 North America POC Diagnostics Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific POC Diagnostics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific POC Diagnostics Market Facts & Figures by Region
7.2.1 Asia-Pacific POC Diagnostics Sales by Region (2020-2031)
7.2.2 Asia-Pacific POC Diagnostics Revenue by Region (2020-2031)
7.3 Asia-Pacific POC Diagnostics Sales by Type (2020-2025)
7.4 Asia-Pacific POC Diagnostics Sales by Application (2020-2025)
8 Europe
8.1 Europe POC Diagnostics Market Size YoY Growth 2020-2031
8.2 Europe POC Diagnostics Market Facts & Figures by Country
8.2.1 Europe POC Diagnostics Sales by Country (2020-2031)
8.2.2 Europe POC Diagnostics Revenue by Country (2020-2031)
8.3 Europe POC Diagnostics Sales by Type (2020-2025)
8.4 Europe POC Diagnostics Sales by Application (2020-2025)
9 Latin America
9.1 Latin America POC Diagnostics Market Size YoY Growth 2020-2031
9.2 Latin America POC Diagnostics Market Facts & Figures by Country
9.2.1 Latin America POC Diagnostics Sales by Country (2020-2031)
9.2.2 Latin America POC Diagnostics Revenue by Country (2020-2031)
9.3 Latin America POC Diagnostics Sales by Type (2020-2025)
9.4 Latin America POC Diagnostics Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America POC Diagnostics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa POC Diagnostics Market Facts & Figures by Country
10.2.1 Middle East and Africa POC Diagnostics Sales by Country (2020-2031)
10.2.2 Middle East and Africa POC Diagnostics Revenue by Country (2020-2031)
10.3 Middle East and Africa POC Diagnostics Sales by Type (2020-2025)
10.4 Middle East and Africa POC Diagnostics Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 POC Diagnostics Supply Chain Analysis
11.2 POC Diagnostics Key Raw Materials and Upstream Suppliers
11.3 POC Diagnostics Clients Analysis
11.4 POC Diagnostics Sales Channel and Sales Model Analysis
11.4.1 POC Diagnostics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 POC Diagnostics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 POC Diagnostics Distributors
12 POC Diagnostics Market Dynamics
12.1 POC Diagnostics Industry Trends
12.2 POC Diagnostics Market Drivers
12.3 POC Diagnostics Market Challenges
12.4 POC Diagnostics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global POC Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global POC Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global POC Diagnostics Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global POC Diagnostics Sales by Region (2020-2025) & (K Units)
 Table 5. Global POC Diagnostics Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global POC Diagnostics Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global POC Diagnostics Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global POC Diagnostics Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global POC Diagnostics Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global POC Diagnostics Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global POC Diagnostics Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global POC Diagnostics Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global POC Diagnostics Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global POC Diagnostics Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global POC Diagnostics Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global POC Diagnostics Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global POC Diagnostics Sales Share by Manufacturer (2020-2025)
 Table 18. POC Diagnostics Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. POC Diagnostics Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers POC Diagnostics Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top POC Diagnostics Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global POC Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global POC Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POC Diagnostics as of 2024)
 Table 24. POC Diagnostics Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into POC Diagnostics Market
 Table 26. Manufacturers POC Diagnostics Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Alere Company Information
 Table 29. Alere Description and Business Overview
 Table 30. Alere POC Diagnostics Product
 Table 31. Alere POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Alere Sales Proportion of POC Diagnostics by Product in 2024
 Table 33. Alere Sales Proportion of POC Diagnostics by Application in 2024
 Table 34. Alere Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 35. Alere Recent Developments
 Table 36. Roche Company Information
 Table 37. Roche Description and Business Overview
 Table 38. Roche POC Diagnostics Product
 Table 39. Roche POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Roche Sales Proportion of POC Diagnostics by Product in 2024
 Table 41. Roche Sales Proportion of POC Diagnostics by Application in 2024
 Table 42. Roche Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 43. Roche Recent Developments
 Table 44. Abbott Laboratories Company Information
 Table 45. Abbott Laboratories Description and Business Overview
 Table 46. Abbott Laboratories POC Diagnostics Product
 Table 47. Abbott Laboratories POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Abbott Laboratories Sales Proportion of POC Diagnostics by Product in 2024
 Table 49. Abbott Laboratories Sales Proportion of POC Diagnostics by Application in 2024
 Table 50. Abbott Laboratories Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 51. Abbott Laboratories Recent Developments
 Table 52. Johnson & Johnson Company Information
 Table 53. Johnson & Johnson Description and Business Overview
 Table 54. Johnson & Johnson POC Diagnostics Product
 Table 55. Johnson & Johnson POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Johnson & Johnson Sales Proportion of POC Diagnostics by Product in 2024
 Table 57. Johnson & Johnson Sales Proportion of POC Diagnostics by Application in 2024
 Table 58. Johnson & Johnson Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 59. Johnson & Johnson Recent Developments
 Table 60. Siemens Healthcare Company Information
 Table 61. Siemens Healthcare Description and Business Overview
 Table 62. Siemens Healthcare POC Diagnostics Product
 Table 63. Siemens Healthcare POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Siemens Healthcare Sales Proportion of POC Diagnostics by Product in 2024
 Table 65. Siemens Healthcare Sales Proportion of POC Diagnostics by Application in 2024
 Table 66. Siemens Healthcare Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 67. Siemens Healthcare Recent Developments
 Table 68. Danaher Company Information
 Table 69. Danaher Description and Business Overview
 Table 70. Danaher POC Diagnostics Product
 Table 71. Danaher POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Danaher Sales Proportion of POC Diagnostics by Product in 2024
 Table 73. Danaher Sales Proportion of POC Diagnostics by Application in 2024
 Table 74. Danaher Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 75. Danaher Recent Developments
 Table 76. Bayer Healthcare Company Information
 Table 77. Bayer Healthcare Description and Business Overview
 Table 78. Bayer Healthcare POC Diagnostics Product
 Table 79. Bayer Healthcare POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Bayer Healthcare Sales Proportion of POC Diagnostics by Product in 2024
 Table 81. Bayer Healthcare Sales Proportion of POC Diagnostics by Application in 2024
 Table 82. Bayer Healthcare Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 83. Bayer Healthcare Recent Developments
 Table 84. Beckman Coulter Company Information
 Table 85. Beckman Coulter Description and Business Overview
 Table 86. Beckman Coulter POC Diagnostics Product
 Table 87. Beckman Coulter POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Beckman Coulter Sales Proportion of POC Diagnostics by Product in 2024
 Table 89. Beckman Coulter Sales Proportion of POC Diagnostics by Application in 2024
 Table 90. Beckman Coulter Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 91. Beckman Coulter Recent Developments
 Table 92. Nipro Diagnostics Company Information
 Table 93. Nipro Diagnostics Description and Business Overview
 Table 94. Nipro Diagnostics POC Diagnostics Product
 Table 95. Nipro Diagnostics POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Nipro Diagnostics Sales Proportion of POC Diagnostics by Product in 2024
 Table 97. Nipro Diagnostics Sales Proportion of POC Diagnostics by Application in 2024
 Table 98. Nipro Diagnostics Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 99. Nipro Diagnostics Recent Developments
 Table 100. Bio-Rad Laboratories Company Information
 Table 101. Bio-Rad Laboratories Description and Business Overview
 Table 102. Bio-Rad Laboratories POC Diagnostics Product
 Table 103. Bio-Rad Laboratories POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 104. Bio-Rad Laboratories Sales Proportion of POC Diagnostics by Product in 2024
 Table 105. Bio-Rad Laboratories Sales Proportion of POC Diagnostics by Application in 2024
 Table 106. Bio-Rad Laboratories Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 107. Bio-Rad Laboratories Recent Developments
 Table 108. Nova Biomedical Company Information
 Table 109. Nova Biomedical Description and Business Overview
 Table 110. Nova Biomedical POC Diagnostics Product
 Table 111. Nova Biomedical POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 112. Nova Biomedical Sales Proportion of POC Diagnostics by Product in 2024
 Table 113. Nova Biomedical Sales Proportion of POC Diagnostics by Application in 2024
 Table 114. Nova Biomedical Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 115. Nova Biomedical Recent Developments
 Table 116. BioMerieux Company Information
 Table 117. BioMerieux Description and Business Overview
 Table 118. BioMerieux POC Diagnostics Product
 Table 119. BioMerieux POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 120. BioMerieux Sales Proportion of POC Diagnostics by Product in 2024
 Table 121. BioMerieux Sales Proportion of POC Diagnostics by Application in 2024
 Table 122. BioMerieux Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 123. BioMerieux Recent Developments
 Table 124. Quidel Company Information
 Table 125. Quidel Description and Business Overview
 Table 126. Quidel POC Diagnostics Product
 Table 127. Quidel POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Quidel Sales Proportion of POC Diagnostics by Product in 2024
 Table 129. Quidel Sales Proportion of POC Diagnostics by Application in 2024
 Table 130. Quidel Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 131. Quidel Recent Developments
 Table 132. Helena Laboratories Company Information
 Table 133. Helena Laboratories Description and Business Overview
 Table 134. Helena Laboratories POC Diagnostics Product
 Table 135. Helena Laboratories POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 136. Helena Laboratories Sales Proportion of POC Diagnostics by Product in 2024
 Table 137. Helena Laboratories Sales Proportion of POC Diagnostics by Application in 2024
 Table 138. Helena Laboratories Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 139. Helena Laboratories Recent Developments
 Table 140. OraSure Technologies Company Information
 Table 141. OraSure Technologies Description and Business Overview
 Table 142. OraSure Technologies POC Diagnostics Product
 Table 143. OraSure Technologies POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 144. OraSure Technologies Sales Proportion of POC Diagnostics by Product in 2024
 Table 145. OraSure Technologies Sales Proportion of POC Diagnostics by Application in 2024
 Table 146. OraSure Technologies Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 147. OraSure Technologies Recent Developments
 Table 148. Accriva Company Information
 Table 149. Accriva Description and Business Overview
 Table 150. Accriva POC Diagnostics Product
 Table 151. Accriva POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 152. Accriva Sales Proportion of POC Diagnostics by Product in 2024
 Table 153. Accriva Sales Proportion of POC Diagnostics by Application in 2024
 Table 154. Accriva Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 155. Accriva Recent Developments
 Table 156. Abaxis Company Information
 Table 157. Abaxis Description and Business Overview
 Table 158. Abaxis POC Diagnostics Product
 Table 159. Abaxis POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 160. Abaxis Sales Proportion of POC Diagnostics by Product in 2024
 Table 161. Abaxis Sales Proportion of POC Diagnostics by Application in 2024
 Table 162. Abaxis Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 163. Abaxis Recent Developments
 Table 164. Chembio Diagnostics Company Information
 Table 165. Chembio Diagnostics Description and Business Overview
 Table 166. Chembio Diagnostics POC Diagnostics Product
 Table 167. Chembio Diagnostics POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 168. Chembio Diagnostics Sales Proportion of POC Diagnostics by Product in 2024
 Table 169. Chembio Diagnostics Sales Proportion of POC Diagnostics by Application in 2024
 Table 170. Chembio Diagnostics Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 171. Chembio Diagnostics Recent Developments
 Table 172. Trinity Biotech Company Information
 Table 173. Trinity Biotech Description and Business Overview
 Table 174. Trinity Biotech POC Diagnostics Product
 Table 175. Trinity Biotech POC Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 176. Trinity Biotech Sales Proportion of POC Diagnostics by Product in 2024
 Table 177. Trinity Biotech Sales Proportion of POC Diagnostics by Application in 2024
 Table 178. Trinity Biotech Sales Proportion of POC Diagnostics by Geographic Area in 2024
 Table 179. Trinity Biotech Recent Developments
 Table 180. North America POC Diagnostics Sales by Country (2020-2025) & (K Units)
 Table 181. North America POC Diagnostics Sales by Country (2026-2031) & (K Units)
 Table 182. North America POC Diagnostics Revenue by Country (2020-2025) & (US$ Million)
 Table 183. North America POC Diagnostics Revenue by Country (2026-2031) & (US$ Million)
 Table 184. North America POC Diagnostics Sales by Type (2020-2025) & (K Units)
 Table 185. North America POC Diagnostics Sales by Application (2020-2025) & (K Units)
 Table 186. Asia-Pacific POC Diagnostics Sales by Region (2020-2025) & (K Units)
 Table 187. Asia-Pacific POC Diagnostics Sales by Region (2026-2031) & (K Units)
 Table 188. Asia-Pacific POC Diagnostics Revenue by Region (2020-2025) & (US$ Million)
 Table 189. Asia-Pacific POC Diagnostics Revenue by Region (2026-2031) & (US$ Million)
 Table 190. Asia-Pacific POC Diagnostics Sales by Type (2020-2025) & (K Units)
 Table 191. Asia-Pacific POC Diagnostics Sales by Application (2020-2025) & (K Units)
 Table 192. Europe POC Diagnostics Sales by Country (2020-2025) & (K Units)
 Table 193. Europe POC Diagnostics Sales by Country (2026-2031) & (K Units)
 Table 194. Europe POC Diagnostics Revenue by Country (2020-2025) & (US$ Million)
 Table 195. Europe POC Diagnostics Revenue by Country (2026-2031) & (US$ Million)
 Table 196. Europe POC Diagnostics Sales by Type (2020-2025) & (K Units)
 Table 197. Europe POC Diagnostics Sales by Application (2020-2025) & (K Units)
 Table 198. Latin America POC Diagnostics Sales by Country (2020-2025) & (K Units)
 Table 199. Latin America POC Diagnostics Sales by Country (2026-2031) & (K Units)
 Table 200. Latin America POC Diagnostics Revenue by Country (2020-2025) & (US$ Million)
 Table 201. Latin America POC Diagnostics Revenue by Country (2026-2031) & (US$ Million)
 Table 202. Latin America POC Diagnostics Sales by Type (2020-2025) & (K Units)
 Table 203. Latin America POC Diagnostics Sales by Application (2020-2025) & (K Units)
 Table 204. Middle East and Africa POC Diagnostics Sales by Country (2020-2025) & (K Units)
 Table 205. Middle East and Africa POC Diagnostics Sales by Country (2026-2031) & (K Units)
 Table 206. Middle East and Africa POC Diagnostics Revenue by Country (2020-2025) & (US$ Million)
 Table 207. Middle East and Africa POC Diagnostics Revenue by Country (2026-2031) & (US$ Million)
 Table 208. Middle East and Africa POC Diagnostics Sales by Type (2020-2025) & (K Units)
 Table 209. Middle East and Africa POC Diagnostics Sales by Application (2020-2025) & (K Units)
 Table 210. POC Diagnostics Key Raw Materials, Industry Status and Trend
 Table 211. POC Diagnostics Key Raw Materials and Upstream Suppliers
 Table 212. POC Diagnostics Clients Status and Trend
 Table 213. POC Diagnostics Typical Clients
 Table 214. POC Diagnostics Distributors
 Table 215. POC Diagnostics Market Trends
 Table 216. POC Diagnostics Market Drivers
 Table 217. POC Diagnostics Market Challenges
 Table 218. POC Diagnostics Market Restraints
 Table 219. Research Programs/Design for This Report
 Table 220. Key Data Information from Secondary Sources
 Table 221. Key Data Information from Primary Sources
 Table 222. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. POC Diagnostics Product Picture
 Figure 2. Global POC Diagnostics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global POC Diagnostics Sales Market Share by Type in 2024 & 2031
 Figure 4. Blood Glucose Testing Product Picture
 Figure 5. Infectious Diseases Testing Product Picture
 Figure 6. Cardiac Markers Testing Product Picture
 Figure 7. Coagulation Testing Product Picture
 Figure 8. Pregnancy and Fertility Testing Product Picture
 Figure 9. Blood Gas or Electrolytes Testing Product Picture
 Figure 10. Tumor Markers Testing Product Picture
 Figure 11. Urinalysis Testing Product Picture
 Figure 12. Cholesterol Testing Product Picture
 Figure 13. Global POC Diagnostics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 14. Global POC Diagnostics Sales Market Share by Application in 2024 & 2031
 Figure 15. Clinics
 Figure 16. Hospitals
 Figure 17. Laboratory
 Figure 18. Others
 Figure 19. POC Diagnostics Report Years Considered
 Figure 20. Global POC Diagnostics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global POC Diagnostics Market Size 2020-2031 (US$ Million)
 Figure 22. Global POC Diagnostics Sales 2020-2031 (K Units)
 Figure 23. Global POC Diagnostics Sales Market Share Forecast by Region (2020-2031)
 Figure 24. Global POC Diagnostics Revenue Market Share by Region (2020-2031)
 Figure 25. Global POC Diagnostics Sales Market Share Forecast by Type (2020-2031)
 Figure 26. Global POC Diagnostics Revenue Market Share Forecast by Type (2020-2031)
 Figure 27. POC Diagnostics Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 28. Global POC Diagnostics Sales Market Share Forecast by Application (2020-2031)
 Figure 29. Global POC Diagnostics Revenue Market Share Forecast by Application (2020-2031)
 Figure 30. POC Diagnostics Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 31. Blood Glucose Testing of POC Diagnostics Revenue Market Share by Application, 2024 VS 2031
 Figure 32. Infectious Diseases Testing of POC Diagnostics Revenue Market Share by Application, 2024 VS 2031
 Figure 33. Cardiac Markers Testing of POC Diagnostics Revenue Market Share by Application, 2024 VS 2031
 Figure 34. Coagulation Testing of POC Diagnostics Revenue Market Share by Application, 2024 VS 2031
 Figure 35. Pregnancy and Fertility Testing of POC Diagnostics Revenue Market Share by Application, 2024 VS 2031
 Figure 36. Blood Gas or Electrolytes Testing of POC Diagnostics Revenue Market Share by Application, 2024 VS 2031
 Figure 37. Tumor Markers Testing of POC Diagnostics Revenue Market Share by Application, 2024 VS 2031
 Figure 38. Urinalysis Testing of POC Diagnostics Revenue Market Share by Application, 2024 VS 2031
 Figure 39. Cholesterol Testing of POC Diagnostics Revenue Market Share by Application, 2024 VS 2031
 Figure 40. Global POC Diagnostics Sales Share by Manufacturer in 2024
 Figure 41. POC Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 42. Blood Glucose Testing Market Sales Proportion by Manufacturer in 2024
 Figure 43. Infectious Diseases Testing Market Sales Proportion by Manufacturer in 2024
 Figure 44. Cardiac Markers Testing Market Sales Proportion by Manufacturer in 2024
 Figure 45. Coagulation Testing Market Sales Proportion by Manufacturer in 2024
 Figure 46. Pregnancy and Fertility Testing Market Sales Proportion by Manufacturer in 2024
 Figure 47. Blood Gas or Electrolytes Testing Market Sales Proportion by Manufacturer in 2024
 Figure 48. Tumor Markers Testing Market Sales Proportion by Manufacturer in 2024
 Figure 49. Urinalysis Testing Market Sales Proportion by Manufacturer in 2024
 Figure 50. Cholesterol Testing Market Sales Proportion by Manufacturer in 2024
 Figure 51. North America POC Diagnostics Revenue 2020-2031 (US$ Million)
 Figure 52. North America POC Diagnostics Sales Market Share by Type (2020-2025)
 Figure 53. North America POC Diagnostics Sales Market Share by Application (2020-2025)
 Figure 54. Asia-Pacific POC Diagnostics Revenue 2020-2031 (US$ Million)
 Figure 55. Asia-Pacific POC Diagnostics Sales Market Share by Region (2020-2031)
 Figure 56. Asia-Pacific POC Diagnostics Revenue Market Share by Region (2020-2031)
 Figure 57. Asia-Pacific POC Diagnostics Sales Market Share by Type (2020-2025)
 Figure 58. Asia-Pacific POC Diagnostics Sales Market Share by Application (2020-2025)
 Figure 59. Europe POC Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 60. Europe POC Diagnostics Sales Market Share by Country (2020-2031)
 Figure 61. Europe POC Diagnostics Revenue Market Share by Country (2020-2031)
 Figure 62. Europe POC Diagnostics Sales Market Share by Type (2020-2025)
 Figure 63. Europe POC Diagnostics Sales Market Share by Application (2020-2025)
 Figure 64. Latin America POC Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 65. Latin America POC Diagnostics Sales Market Share by Country (2020-2031)
 Figure 66. Latin America POC Diagnostics Revenue Market Share by Country (2020-2025)
 Figure 67. Latin America POC Diagnostics Sales Market Share by Type (2020-2025)
 Figure 68. Latin America POC Diagnostics Sales Market Share by Application (2020-2025)
 Figure 69. Middle East and Africa POC Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 70. Middle East and Africa POC Diagnostics Sales Market Share by Country (2020-2031)
 Figure 71. Middle East and Africa POC Diagnostics Revenue Market Share by Country (2020-2031)
 Figure 72. Middle East and Africa POC Diagnostics Sales Market Share by Type (2020-2025)
 Figure 73. Middle East and Africa POC Diagnostics Sales Market Share by Application (2020-2025)
 Figure 74. POC Diagnostics Supply Chain (Upstream and Downstream Market)
 Figure 75. Global Production Market Share of POC Diagnostics Raw Materials by Region in 2024
 Figure 76. POC Diagnostics Distribution Channels
 Figure 77. Global POC Diagnostics Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 78. Global POC Diagnostics Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 79. Bottom-up and Top-down Approaches for This Report
 Figure 80. Data Triangulation
 Figure 81. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS